Alan Schafer to head Population Genetics

07-05-2012: Population Genetics Technologies Ltd. has appointed Alan Schafer, PhD to the post of Chief Executive Officer.

Schafer brings deep experience in research, “big pharma” management and building new businesses. He is Adjunct Professor of Innovation at Imperial College London Business School and was previously the Wellcome Trust’s Director of Science Funding. Before that he served as Global Vice-President of Technology Development at GlaxoSmithKline and co-founded Hexagen, a functional genomics company and subsequently acquired by Incyte. He will continue to serve on a number of research and venture capital advisory boards.

Facts, background information, dossiers
  • Population Genetics…
More about Population Genetics Technologies
  • News

    Alan Schafer to head Population Genetics

    Population Genetics Technologies Ltd. has appointed Alan Schafer, PhD to the post of Chief Executive Officer. Schafer brings deep experience in research, “big pharma” management and building new businesses. He is Adjunct Professor of Innovation at Imperial College London Business School and ... more

    Mass Analysis of DNA from Whole Populations

    Nobel Prize winner Dr Sydney Brenner has devised a new method for obtaining sequence information from thousands of genomes simultaneously. Current technologies can only analyse one genome at a time. This method, to be developed by a new company called Population Genetics Technologies, is ex ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE